New bladder pain treatment shows promise in early trial

NCT ID NCT06394830

Recruiting now Symptom relief Sponsor: Vaneltix Pharma, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a drug called VNX001 for people with Interstitial Cystitis (a painful bladder condition) who have sudden, moderate-to-severe bladder pain. About 50 adults will receive up to 6 doses of the drug directly into the bladder over 14 days. The goal is to see if the drug safely reduces pain and how often it is needed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER PAIN SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

interstitial cystitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLADDER PAIN SYNDROME INTERSTITIAL CYSTITIS

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Arizona Urology Specialists
COMPLETED

Tucson, Arizona, 85715, United States
Georgia Urology
RECRUITING

Cartersville, Georgia, 30120, United States
Oregon Urology Institute
RECRUITING

Springfield, Oregon, 97477, United States
Prestige Medical Group
SUSPENDED

Tustin, California, 92780, United States
Valley Urology, Inc.
SUSPENDED

Fresno, California, 93710, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.